| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BDTX | Black Diamond Therapeutics, Inc. | Officer Title: Chief Operating Officer and General Counsel | Feb 14, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
|---|